baber/WOPTO huggingface dataset:
Patent NZ-592489-A (NZ)
Title: Skirting comprising a pre-formed holes and double sided adhesive for attachment to a wall
Inventor: MACCOLL DON
IPC: E04F19/04
Filed: 2011-04-27
Abstract: Disclosed is a skirting (2) that is used as a cover for covering the lowest part of an internal wall to cover the joint between the wall surface and the floor. The skirting (2) includes a body (4) and an adhesive tape that is adhered to the body for attaching the body (4) to the wall. The body (4) defines a plurality of spaced apart holes (14). The holes (14) are pre-formed prior to attaching the body (4) to the wall.
Patent NZ-592510-A (NZ)
Title: HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same
Inventor: SUGIYAMA HARUO
IPC: C12N5/0786
Filed: 2007-12-14
Abstract: Disclosed is the use of a peptide having an ability to bind to an HLA-A*1101 molecule, and an ability to induce a cytotoxic T lymphocyte comprising the amino acid sequence Ser Ala Ser Glu Thr Ser Slu Lys Arg, wherein one to five amino acids may be substituted with other amino acids, in the manufacture of a medicament for the treatment or prevention of cancer in an HLA-A*1101-positive subject, provided said patient is not HLA-A*3101-positive.
Patent NZ-593953-A (NZ)
Title: Mechanical lockings of floor panels and a tongue blank
Inventor: BOO CHRISTIAN
IPC: E04F15/02
Filed: 2009-11-02
Abstract: 593953 A tongue blank 80 comprising at least two tongues 30 having a tongue length TL and being connected to each other and adapted to be separated from each other and inserted into an edge groove of a floor panel, wherein each tongue comprises a main tongue body 30a comprising at least two protrusions extending essentially in the tongue length direction and two recesses, the tongue comprises at least two wedge parts 45 located at least partly in or adjacent to the recesses, and the main tongue body 30a and the wedge parts 45 comprise releasable wedge part connections adapted to be released from the main tongue body 30a during the insertion of the tongue 30 into the groove.
Patent NZ-594514-A (NZ)
Title: Interleukin-17 BINDING PROTEINS
Inventor: HSIEH CHUNG-MING
IPC: A61K39/395
Filed: 2010-03-05
Abstract: 594514 IL-17 BINDING PROTEINS Provided is binding protein comprising an antigen binding domain, wherein said binding protein binds human IL-17, said antigen binding domain comprises six CDRs with defined sequences. Corresponding DNA sequences for the variable domains are also provided. The antibodies can be used to treat a variety of diseases, including inflammation, autoimmunity and cancer.
Patent NZ-597338-A (NZ)
Title: Method for operating an access control system
Inventor: FRIEDLI PAUL
IPC: G07C9/00
Filed: 2010-06-25
Abstract: 597338 Disclosed is a method for operating an access control system with at least one door fitting (1) controlling access to a secured area of a building and at least one identification code on a mobile data carrier (2). The identification code is read in by a reader (10) of the door fitting (1) or at least one of the door fittings. If the read-in identification code is valid, access to the area secured by the door fitting (1) is granted. A computer unit (3) communicates an authorisation code to a central computer unit (4) via at least one communicative connection (41) and a check is made to determine whether the communicated authorisation code corresponds to a valid authorisation code for an area profile of the area, or at least part of the area, secured by the door fitting (1). Upon successful checking of the communicated authorisation code, write and read rights for the area profile are released to the computer unit (3) that communicated the authorisation code. The released area profile is changeable by the computer unit (3) via a communicative connection (41). The computer unit (3) creates the identification code of the mobile data carrier (2) in a released area profile as a provisional identification code. If the reader (10) of the door fitting (1) that grants access to the secured area of the released area profile reads in an identification code corresponding to the provisional identification code, the read-in identification code is included in the released area profile as a valid identification code. Systems and computer programs for performing the method are also disclosed.
Patent NZ-597545-A (NZ)
Title: Peptide epoxyketones for proteasome inhibition
Inventor: SHENK KEVIN D
IPC: A61K31/336
Filed: 2007-06-19
Abstract: Disclosed are amido compounds of formula (I), salts thereof, and methods for their preparation. Also disclosed is the use of the compounds of formula (I) for treating cancer, immune-related disease, inflammation, infection and neurodegenerative diseases.
Patent NZ-597777-A (NZ)
Title: Motilin-like peptide compound having transmucosal absorbability imparted thereto
Inventor: SATO SEIJI
IPC: A61P1/00
Filed: 2010-07-29
Abstract: Disclosed is a motilin derivative compound comprising the sequence represented by the following general formula 1: X1 Val X2 lIe Phe Thr Tyr Gly X3 Leu GIn Arg X4 GIn Glu Lys Glu Arg X5 Lys Pro Gln (XVXIFTYGXLQRXQEKERXKPQ). Further disclosed are compounds which is depicted by the sequence selected from the group consisting of SEQ ID NOS: 3 to 15 or a pharmaceutically acceptable salt thereof. alpha
Patent NZ-598251-A (NZ)
Title: 2-Arylamino-pyridopyrimidines and their uses, particularly in the treatment of cancer
Inventor: SHI XIAN
IPC: A61K31/4375
Filed: 2008-03-13
Abstract: 598251 Disclosed are 2-arylamino-pyridopyrimidines as represented by the general formula (I) where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, wherein: R1 is alkyl, cycloalkyl, phenyl, or heteroaryl where the cycloalkyl, phenyl, and heteroaryl are optionally substituted with 1, 2, or 3 R6; R2 and R3 together with the pyrimidine ring to which they are attached form a pyrido[3,2-d]pyrimidine, pyrido[4,3-d]pyrimidine, pyrido[3,4-d]pyrimidine, or pyrido[2,3-d]pyrimidine moiety, each of which is optionally substituted at a carbon atom at the 5-, 6-, 7-, and 8-positions with one or two groups independently selected from alkyl, alkoxy, halo, hydroxy, heterocycloalkylalkyloxy, heterocycloalkyl, and heterocycloalkyl substituted with alkyl; or R2 and R3 together with the pyrimidine ring to which they are attached form a 5,6,7,8-tetrahydropyrido[3,2-d]pyrimidine, 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine, 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine, or 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine moiety, each of which is optionally substituted at the 5-, 6-, 7-, and 8-positions with one or two groups independently selected from alkyl, alkoxycarbonyl, benzyloxycarbonyl, and optionally substituted phenylalkyl; and wherein the remaining substituents are as defined herein. Of particular importance is the compound N-[2-methyl-5-(morpholin-4-ylmethyl)phenyl]-4-[(4-phenylpyrido[2,3-d]pyrimidin-2-yl)amino]benzamide; and a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof. Further disclosed is a composition comprising a compound as defined above, and a pharmaceutically acceptable carrier, excipient, or diluent; for treating a disease mediated by a protein in the Hedgehog pathway, such as cancer, and particularly for the treatment of basal cell carcinoma, medulloblastoma, rhabdomyosaracoma, pancreatic cancer, breast carcinoma, meningioma, glioblastoma, melanoma, stomach cancer, esophageal cancer, biliary tract cancer, prostate cancer, small cell lung cancer, non-small cell lung cancer, glial cell cancer, multiple myeloma, chronic myeloid leukemia, testicular cancer, ovarian cancer, and colon cancer.
Patent NZ-602721-A (NZ)
Title: Parasiticidal compositions comprising multiple active agents, methods and uses thereof
Inventor: DAS-NANDY ARIMA
IPC: A01N43/00
Filed: 2011-04-01
Abstract: This disclosure relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole of formula (I), at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. The compositions generally comprises four active agents: two contact-acting active agents and two systemically-acting-active agents. This disclosure also provides for an improved method for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the disclosure to the animal in need thereof.
Patent NZ-603876-A (NZ)
Title: Nitrogen heterocyclic compounds useful as pde10 inhibitors
Inventor: HARRINGTON ESSA HU
IPC: C07D491/08
Filed: 2011-05-11
Abstract: Disclosed are unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington’s Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like. Examples of compounds of formula (I) are: (1H-Benzoimidazol-2-yl)-[3-(3-phenyl-pyridin-2-yl)-azetidin-1-yI]-methanone; (1H-Benzoimidazol-2-yl)-[3-(5-fluoro-3-phenyl-pyridin-2-yl)-azetidin-1-yl]-methanone; (1H-benzoimidazol-2-yl)-[4-(3-phenyl-pyrazin-2-yl)-piperidin-1-yI]-methanone; Benzothiazo1-2-yl-(3-(3-phenyI-pyrazin-2-yI)-azetidin-1-yl]-methanone.
Patent NZ-607832-A (NZ)
Title: Multilayer lignocellulose-containing moldings having low formaldehyde emission
Inventor: ROSCHMANN KONRAD
IPC: C09J133/02
Filed: 2011-08-29
Abstract: Disclosed herein is a multilayer lignocellulose-containing molding comprising A) a middle layer or a plurality of middle layers comprising lignocellulose-containing particles which is/are obtainable by using a binder (a) and B) a covering layer or a plurality of covering layers comprising lignocellulose-containing particles which is/are obtainable by using a binder (b), the binder (a) being selected from the group consisting of (a1) formaldehyde resins and (a2) an organic isocyanate having at least two isocyanate groups; the binder (b) comprising the following components: an aqueous component (I) comprising (i) a polymer A which is composed of the following monomers: a) from 70 to 100% by weight of at least one ethylenically unsaturated mono- and/or dicarboxylic acid (monomer(s) A1) and b) from 0 to 30% by weight of at least one further ethylenically unsaturated monomer which differs from the monomers A1 (monomer(s) A2) optionally (ii) a low molecular weight crosslinking agent having at least two functional groups which are selected from the group consisting of hydroxyl, carboxyl and derivatives thereof, primary, secondary and tertiary amine, epoxy, aldehyde, an organic isocyanate having at least two isocyanate groups as component (II) and, optionally, a component (III), as an aqueous dispersion, comprising one or more polymer(s) M which is/are composed of the following monomers: a) from 0 to 50% by weight of at least one ethylenically unsaturated monomer which comprises at least one epoxide and/or at least one hydroxyalkyl group (monomer(s) M1) and b) from 50 to 100% by weight of at least one further ethylenically unsaturated monomer which differs from the monomers M1 (monomer(s) M2) and, optionally, customary additives as component (IV), and the binder (b) optionally comprises a formaldehyde scavenger.
Patent NZ-620460-A (NZ)
Title: Procedure for the preservation of by-products from the meat industry and other food industries
Inventor: BAEZA ORTEGA FERNANDO
IPC: A61L11/00
Filed: 2012-07-25
Abstract: Disclosed is a procedure for the preservation of by-products from the meat industry and other food industries, for drastically reducing the putrefaction or degradation of such by-products without applying cold and without grinding, milling or disintegrating such by-products, characterized in that simultaneously with each loading of the products into a collecting container, a preservative is pressure incorporated jointly with pressurized air, in order to obtain a nebulisation of the preservative, with a uniform distribution of the same on each layer of the by-product.
Patent NZ-627179-A (NZ)
Title: Substituted nucleosides, nucleotides and analogs thereof
Inventor: SMITH DAVID BERNARD
IPC: C12N9/99
Filed: 2012-12-20
Abstract: Disclosed herein are compounds of formula I, pharmaceutical compositions that include these, and methods of synthesizing the same. Also disclosed herein is the use of the compounds in the manufacture of medicaments for treating a viral infection including an infection from a paramyxovirus and/or an orthomyxovirus.
Patent NZ-628429-A (NZ)
Title: Method of employing enhanced penetration of wood preservatives to protect wood and a related solution
Inventor: ROSS ALAN S
IPC: B27K3/52
Filed: 2012-03-19
Abstract: A method of enhancing penetration of wood preservatives includes providing a solution including (a) at least one amine oxide, (b) at least one amine oxide wood preservative and (c) a dual buffer, the solution being free of any borates, boric acid or borax. The solution preferably has a pH of about 7 to 10.
Patent NZ-629471-A (NZ)
Title: Moldable sand compositions and methods for making the same
Inventor: VADAKETH LEENA
IPC: C09D131/04
Filed: 2013-04-09
Abstract: Disclosed are moldable sand compositions, methods for making the moldable sand compositions, and methods for using the moldable sand compositions. In a particular embodiment, the moldable sand composition comprises between about 70% to about 95% sand, between about 5% to about 30% water, a polar polymeric resin, a crosslinking agent, and a humectant. In an exemplary embodiment, the composition contains no oils, waxes, glycols, or rubbers. The composition is capable of becoming hardened over time in order to maintain the achieved shape, and can be re-wetted and molded again after becoming hardened.
Patent NZ-708968-A (NZ)
Title: Optical fiber distribution system
Inventor: VAN DE WEYER DIRK JOZEF G
IPC: H04Q1/00
Filed: 2014-01-29
Abstract: Optical fiber distribution systems include fiber terminations and other equipment which is typically rack mounted. Various concerns exist for the optical fiber distribution systems, including density, ease of use, and cable management. The present invention sets out to solve one or more problems of the prior art by providing an optical fiber distribution system including a rack and elements which populate the rack including fiber terminations. Each element includes a chassis and a movable tray. The movable tray includes a synchronized movement device for moving a cable radius limiter. The tray includes cable terminations which extend in a line generally parallel to a direction of movement of the movable tray. Each of the cable terminations are mounted on hinged frame members positioned on each tray. The cables entering and exiting the movable tray follow a generally S-shaped pathway.
Patent NZ-711893-A (NZ)
Title: Torque alleviating intra-airway lung volume reduction compressive implant structures
Inventor: VASQUEZ JAIME
IPC: A61F2/04
Filed: 2014-03-13
Abstract: A device for enhancing breathing efficiency of a patient is provided. The device may include a deployed configuration with one or more helical sections with proximal end in a stand-off proximal end configuration. The standoff proximal end configuration may reduce migration of the deployed device and may preserve implant tissue compression. Alternative configurations may include two or more helical sections with a transition section disposed between the two or more helical sections. A device may include a right-handed helical section and a left-handed helical section and the transition section comprises a switchback transition section. The switchback section may provide greater control of the device during deployment by limiting recoiling forces of a device comprising a spring material. The deployed device may compress the lung to increase a gas filling resistance of the compressed portion of the lung, and/or increase tension and elastic recoil in other portions of the lung.
Patent NZ-713360-A (NZ)
Title: Novel vaccine compositions comprising immunostimulatory oligonucleotides
Inventor: DOMINOWSKI PAUL
IPC: A61K39/008
Filed: 2014-05-12
Abstract: The invention provides a vaccine composition comprising an antigen component and an adjuvant component, wherein the adjuvant component comprises a P-class immunostimulatory oligonucleotide and either a combination of a saponin and a sterol; or an oily phase comprising an oil and, optionally, one or more emulsifiers, said oily phase comprising 2-20% v/v of the vaccine composition, wherein said antigen component is an EHV antigen or a Leishmania antigen.
Patent NZ-717336-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C08B1/00
Filed: 2011-05-20
Abstract: Discloses a method comprising saccharifing a cellulosic or lignocellulosic material and then fermenting the material with a microorganism in saline water to produce an intermediate or a product. The biomass material could be, for example paper, paper products, wood, wood-related materials, grasses, rice hulls, bagasse, cotton, jute, hemp, flax, bamboo, sisal, abaca, straw, corn cobs, coconut hair, algae, seaweed, microbial materials and synthetic celluloses. Examples of the microorganism include yeast, fungus, algae, mold, bacteria, marine microorganisms or thermophilic microorganisms. The salt water could be seawater, brackish water or any type of brine solution. The method can be used to produce energy, fuels, foods and materials such as carboxylic acids, alcohols and hydrocarbons.
Patent NZ-718144-A (NZ)
Title: Methods and compositions comprising purified recombinant polypeptides
Inventor: YU X CHRISTOPHER
IPC: A61K39/395
Filed: 2014-09-12
Abstract: Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.
Patent NZ-718900-A (NZ)
Title: Complex containing oligonucleotide having immunopotentiating activity and use thereof
Inventor: KASUYA YUJI
IPC: A61K39/39
Filed: 2014-09-19
Abstract: The invention provides an oligodeoxynucleotide containing humanized K-type CpG oligodeoxynucleotide, polydeoxyadenylic acid and lentinan, wherein polydeoxyadenylic acid is located on the 3’ side of the humanized K-type CpG oligodeoxynucleotide. The present invention also provides a complex containing this oligodeoxynucleotide and β-1,3-glucan.
Patent NZ-730947-A (NZ)
Title: Integrated kraft pulp mill and thermochemical conversion system
Inventor: ROWLANDS WILLIAM NEIL
IPC: D21C11/00
Filed: 2015-10-14
Abstract: This disclosure pertains to the use of black liquors from kraft pulp mills as a source of catalysts for the thermochemical conversion of organic matter feedstocks to bio oils. More particularly, some embodiments pertain to integrated kraft pulp mill and thermochemical conversion systems, which include: a Kraft pulp mill comprising a digester for digesting a lignocellulosic material with white liquor to produce pulp and black liquors; a thermochemical conversion subsystem comprising: at least one mixing tank for combining pulping liquors received from the pulp mill with an organic matter feedstock and water to produce a reaction mixture; a reactor vessel for treating the reaction mixture received from the mixing tank at a reaction temperature and pressure suitable for conversion of all or a portion of the organic matter in the reaction mixture into a product mixture comprising a bioproduct and an aqueous stream containing both organic and inorganic compounds; wherein the organic matter feedstock is lignocellulosic feedstock; a depressurizer for depressurizing product mixture received from the reactor vessel; and one or more conveyors for conveying the pulping liquors from the pulp mill to the mixing tank.
Patent NZ-739721-A (NZ)
Title: Antigen binding constructs to target molecules
Inventor: CHAN CHIO
IPC: C07K16/00
Filed: 2016-08-04
Abstract: In some embodiments, amino acid sequences are described. The amino acid sequences can be used in hinges of antibody constructs. The first hinge cysteine that usually pairs with light chain in native IgG1, IgG2 and IgG3 antibodies can be a serine or alanine or other appropriate amino acid to prevent disulfide scrambling and/or concatamerization. To reduce the presence or reduce the formation of half-molecules and enhance stability in vivo, the hinge region can contain at least three cysteins to form at least three disulfide bonds with the other monomer. Three disulfide bonds in the hinge within the minibody located at appropriate distances from one another are useful for protein stability in vivo and clearance through liver rather than renal clearance.
Patent NZ-747132-A (NZ)
Title: Cooling apparatus for carbonized biomass
Inventor: TANO TATSUMI
IPC: C10L5/30
Filed: 2017-04-03
Abstract: An apparatus for producing carbonised biomass includes a rotary kiln (1) for carbonizing biomass moulded bodies to obtain a carbonized biomass; a classifying means (21) which is disposed on the downstream side of the carbonizing furnace and which is for classifying the carbonized biomass; and a cooling means (22a) which is disposed on the downstream side of the classifying means and which is for cooling the classified carbonized biomass with a water spray. The biomass moulded bodies are obtained by pulverization and subsequent moulding of a starting material biomass. Carbonizing the moulded biomass includes thermal decomposition of the moulded biomass. Using a water spray on the semi-carbonized moulded biomass after any particles have been removed by the classifier improves the cooling efficiency while reducing clogging in a facility.
Patent NZ-747734-A (NZ)
Title: Ventilated container for produce
Inventor: PICKARD KEITH
IPC: B65D85/34
Filed: 2017-03-24
Abstract: A ventilated container for produce includes a bottom, sidewalls extending upwardly from the bottom, and a rim having a flattened top surface. The sidewalls include at least one ventilation opening located proximate the rim of the container thereby permitting the rim of the container to be generally flat and uninterrupted. The location of ventilation opening(s) proximate the rim of the container allows the flow of rising ethylene gas within the container to exit near the top of the container improving ventilation within the container. A plastic film can be applied over the top of the container and is adhered to the container with an adhesive to form a secure and rigid seal between the film and the container. The flattened surface of the rim improves the adherence between a film and the container to enclose and seal the container, aids the rigidity of the container, and lessens the likelihood of the edges of the rim being bent or folded when pressure is exerted to protect produce provided within the container. Moreover, an aperture on the bottom of the container provides drainage of liquid from the container and allow air to flow.
Patent NZ-753001-A (NZ)
Title: Nutritional compositions providing dietary management of colic
Inventor: MORELLI LORENZO
IPC: A61K35/745
Filed: 2017-10-19
Abstract: A method for reducing the incidence of colic in a pediatric subject is presented, the method including administering to a subject a nutritional composition having about 1 x 10^3 to about 1 x 10^12cfu/100 kcal of LA metabolizing probiotic; up to about 7 g/100 kcal of a fat or lipid; up to about 5 g/100 kcal of a protein or protein equivalent source; about 0.06 g/100 kcal to about 1.5 g/100 kcal of enriched milk product; about 5mg/100 kcal to about 90 mg/100 kcal of a source of long chain polyunsaturated fatty acids; and about 0.015 g/100 kcal to about 1.5 g/100 kcal of a prebiotic composition. In particular, the present invention relates to an infant nutritional composition comprising Bifidobacterium breve (B. breve) for treating colic, wherein the number of B. breve is at least one logarithm higher than the number of Blautia bacteria in the gut of the infant following administration of the composition.